Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

News SummaryMost relevantAll newsSector newsTweets 

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
05/17/2013 | 06:55pm CET

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171

SOURCE Levi & Korsinsky, LLP

share with twitter share with LinkedIn share with facebook
share via e-mail
01/24 LIGAND PHARMACEUTICALS : to Host Analyst Day on February 28th in New York City
01/23 LIGAND PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2016 Results on ..
01/18 LIGAND PHARMACEUTICALS INC : Regulation FD Disclosure (form 8-K)
01/13 LIGAND PHARMACEUTICALS INC. : EQUITY NOTICE: Lundin Law PC Announces Securities ..
01/13 UPCOMING DEADLINE : Levi & Korsinsky, LLP Reminds Shareholders of Ligand Pharmac..
01/12 BRAGAR EAGEL & SQUIRE, P.C. REMINDS : LGND and the Lead...
01/12 LIGAND PHARMACEUTICALS INC. : Khang & Khang LLP Announces Securities Class Actio..
01/11 LIGAND PHARMACEUTICALS INC. : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LL..
01/10 LIGAND PHARMACEUTICALS INC. : INVESTOR NOTICE: Lundin Law PC Announces Securitie..
01/09 LGND The Law Offices of Vincent Wong Reminds Investors of a Class Action Invo..
More news
Sector news : Biotechnology & Medical Research - NEC
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
2016 VIKING THERAPEUTICS : Barbaric Value
2016 Ligand inks Captisol deal with Novartis; shares up 1%
2016 BEST NEAR-TERM PRICE GAINS AHEAD FOR : Biotechnology Developers Stocks
2016 Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q3 2016 Results - Earnings..